CING: Cingulate Inc. Stock

by  •  • Comments Off on CING: Cingulate Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 14.62
Enterprise Value ($M) 4.58
Book Value ($M) 12.04
Book Value / Share 3.75
Price / Book 1.21
NCAV ($M) 9.80
NCAV / Share 3.05
Price / NCAV 1.49

Profitability (mra)
Return on Invested Capital (ROIC) -1.33
Return on Assets (ROA) -4.68
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 7.35
Current Ratio 7.35

Balance Sheet (mrq) ($M)
Current Assets 11.34
Assets 13.58
Liabilities 1.54
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-14 13G/A Lind Global Fund II LP 3.10 -64.92
08-30 13D/A Werth Peter J. 4.51 0.00
2024-01-04 13D/A Schaffer Shane J. 3.65 -94.62

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q
2024-04-01 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-01-31 47,103 147,320 31.97
2025-01-30 93,833 264,622 35.46
2025-01-29 86,687 253,939 34.14
2025-01-28 27,088 88,453 30.62
2025-01-27 66,186 137,117 48.27

(click for more detail)

Similar Companies
CELU – Celularity Inc. CELZ – Creative Medical Technology Holdings, Inc.
CGEN – Compugen Ltd. CKPT – Checkpoint Therapeutics, Inc.
CLDX – Celldex Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io